News
Democrats have little to be giddy about these days, but they took pleasure in taunting White House Deputy Chief of Staff Stephen Miller as Elon Musk made his White House exit with Miller’s wife ...
Taysha Gene Therapies, Inc. DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing ...
WICHITA — “I was mind blown. I was shocked.” Ryin Miller crossed the finish line with her hands on her face. She let out a huge smile before the line and immediately buried her face.
(MENAFN- GlobeNewsWire - Nasdaq) DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...
New Zealand Rugby Player of the Year Jorja Miller speaks about transferring to the Black Ferns from the sevens side and her future goals. Video / Alyse Wright Not a lot scares Jorja Miller.
Former Denver Broncos tight end Julius Thomas advocated during a recent appearance on the Up & Adams Show for the team to bring back Super Bowl 50 MVP Von Miller, who remains an unsigned free agent.
It's understandable that Indiana Pacers legend Reggie Miller might want to see his old team win the 2025 Eastern Conference Finals over the New York Knicks. However, it's hard to ignore how a ...
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based ...
Taysha Gene Therapies announced a public offering of shares priced at $2.75 each, aiming for $200 million in gross proceeds. Taysha Gene Therapies successfully priced a public offering of ...
Investing.com -- Shares of Taysha Gene Therapies (NASDAQ:TSHA) soared 19% today after the company announced pivotal trial design details for TSHA-102 in Rett Syndrome, which were enabled by IRSF ...
White House Deputy Chief of Staff Stephen Miller called out CNN's Pamela Brown's "lazy assumptions" regarding the Trump administration's executive power during an appearance on "The Situation Room ...
Shares of Taysha Gene Therapies climbed after the company announced details of a planned trial for its treatment for Rett syndrome and filed for a secondary share offering. The stock rose 13% to $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results